Institutional
27 de July de 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
30 de July de 2026
Raquel Barros Appointed Member of the National Council for Combating Piracy
Kasznar Leonardos is proud to share that Raquel Barros, Partner and Co-Head of Anti-Piracy & Brand Protection, has been elected as one … Raquel Barros Appointed Member of the National Council for Combating Piracy
7 de April de 2026
Kasznar Leonardos was ranked in Chambers Brazil: Contentious 2026
We are proud to announce that we have been ranked in Chambers Brazil: Contentious 2026 by Chambers and Partners. As a firm, … Kasznar Leonardos was ranked in Chambers Brazil: Contentious 2026
13 de March de 2026
Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation
Our firm successfully represented a company operating in the offshore oil and gas sector in a lawsuit challenging the validity of a Brazilian patent … Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation